Two studies report that children who get measles are more susceptible to other illnesses later; Indiana decides not to pursuue Medicaid work requirements; a Trump administration rule taking effect mandating health insurance for new immigrants is causing confusion.
New research shows that children who get the measles may suffer from other illnesses later like flu, strep or pneumonia because of something scientists are calling “immune amnesia.” The Associated Press reported that 2 different studies published this week found that children with the measles produced antibodies to that virus, but other immune systems were basically reset, leaving them vulnerable to other illnesses. Doctors are hoping the findings will be enough to convince parents to get their children vaccinated.Indiana has joined Arizona in deciding not to move forward with plans to force some Medicaid recipients to work or do job training; both states cite federal lawsuits challenging what CMS has called “community engagement” rules that critics say violate the program’s basic purpose. The Washington Post reported that the change means that currently, no Medicaid recipient anywhere is currently at risk of losing coverage for failing to find a job. The 2 Republican-led states are the first to voluntarily step back from the policy; a federal judge in Washington has stopped 3 other states from implementing the change in 3 other states.US citizens hoping to have their relatives join them, legal immigrants, and health insurance companies are swimming through a maze of confusion and bureaucracy as the Trump administration’s new policy goes into effect in November 3 barring prospective immigrants from arriving unless they can prove they will have health insurance, or a way to pay for it, in 30 days. Reuters reported that the administration has not provided many details other than to list the type of plans that will be accepted. While a Social Security number is not required to apply for coverage, insurers may ask for it, a Kaiser Permanente official said.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More